Polari Group is a technology company.
Polari Group has raised $540K across 1 funding round.
Polari Group has raised $540K in total across 1 funding round.
Polari Group has raised $540K in total across 1 funding round.
Polari Group's investors include Chasing Rainbows.
# Polari Group: High-Level Overview
Polari Group is not a technology company in the traditional sense—it is a sexual health and wellness startup developing medical devices and services for anorectal health.[2] Founded in 2023 by Anna Vybornova (a biomedical engineer trained at EPFL and MIT) and Dr. Henry Blest (a chemist and immunologist from Oxford), the company addresses a largely unmet market need through scientific innovation rather than software or digital platforms.[2][4]
The startup's core product is a ball-shaped device designed to be inserted into the rectum before anal sex to prevent what the company calls "faecal accidents."[3] Polari estimates that 2.8 billion anal sex acts occur yearly across the UK, US, and Europe, yet this market segment has historically been underserved by medical innovation.[2][3] The company operates the world's first dedicated anal sex lab in central London, where it studies the biomechanics of anal intercourse to inform product design and safety.[2][4] Beyond the device itself, Polari envisions a comprehensive anorectal health and pleasure platform integrating medical innovation, education, and platform-based services.[2]
# Origin Story
Vybornova and Blest met at Entrepreneur First, an accelerator program, approximately one year before their $539K pre-seed funding announcement in 2024.[2][4] Vybornova brought five years of medtech and biopharma experience, including bringing a medical device to market at Aktiia, a wearable technology company competing with Apple Watch.[2] Blest contributed six years of research expertise in virology and sexually transmitted infections from his time at Oxford University, where he studied how viruses like herpes simplex and HIV evade immune responses.[2]
The founders were motivated by a conviction that medical science should serve all communities, including the LGBTQIA+ population, despite discomfort some investors expressed during fundraising.[2][3][4] This mission-driven approach resonated strongly with impact-focused investors: their funding came from Chasing Rainbows, Ada Ventures' angel programme, Ventures Together, and Little Green Bamboo Capital—investors with explicit focus on LGBTQIA+ communities and sexual health innovation.[2][4]
# Core Differentiators
# Role in the Broader Tech Landscape
Polari Group exemplifies a broader trend of mission-driven deeptech startups addressing taboo or underserved health domains. The company operates at the intersection of sexual health destigmatization, precision medicine, and impact investing—sectors gaining momentum as venture capital increasingly funds solutions for marginalized communities.
The timing is significant: growing acceptance of sexual health as a legitimate medical domain, combined with the rise of LGBTQIA+-focused venture funds, has created a window for companies like Polari to access capital and talent that would have been unavailable a decade ago. The startup's success also signals that investors are willing to back founders tackling uncomfortable topics when the market size is demonstrable and the founding team is credible.
# Quick Take & Future Outlook
Polari Group's planned UK launch in September 2025 (now past) represents a critical inflection point—the transition from research and development to commercial validation.[3] The company's ability to scale manufacturing, expand its team to 7-10 people, and navigate regulatory approval will determine whether it becomes a category-defining player in sexual health innovation or remains a niche player.
The broader opportunity lies not in the initial device but in Polari's stated vision of a comprehensive platform integrating products, education, and services.[2] If successful, the company could establish a template for how medtech founders approach historically stigmatized health categories with scientific rigor and commercial ambition. The polarizing nature of the business—which initially deterred some investors—has become its greatest asset, attracting capital from investors who deeply understand the market and are committed to its success.[4]
Polari Group has raised $540K across 1 funding round. Most recently, it raised $540K Seed in June 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2024 | $540K Seed | Chasing Rainbows |